← Leaderboards
Anna Pavlovna Hnatiuk Hnatiuk
Stanford University
$276,439
Attributed
$276,439
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $154K · FY2023–24$200K$150K$100K$50K$0
'23
'24
Funding mix
By agency
NIH$276,439 · 1
By mechanism
K99$276,439 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Mark Mercola$44,191,191
- Paul W. Burridge$6,528,957
- Thomas None Quertermous$63,279,401
- Joseph Wu$3,969,819
Others in their field
Other Rising Stars on “Acceleration”
- Angee Greer · Ppd Development Lp$82,531,927
- Julia Louise Moore Vogel · Scripps Research Institute, The$32,252,685
- Tim A Bertram · Wake Forest University School Of Medicine$30,163,580
- Nancy Jean Sullivan · Boston University Medical Campus$23,000,000
- Alanna Maguire · Mayo Clinic Rochester$16,353,346
- Michael Hogarth · University Of California, San Diego$15,375,743
Research focus
AccelerationAdverse Drug EffectAdverse EffectsAdvisory CommitteesAffectAnalogAnti-CancerAnticancer ActivityAntineoplastic AgentsBasic ScienceBcr-Abl Fusion ProteinsBioinformaticsBlood VesselsBone Marrow SuppressionCancer PatientCancer SurvivorCancer SurvivorshipCandidate IdentificationCardiacCardiac MyocytesCardiovascular SystemCareerCell LineageAbl1 Gene
Grant awards (2)
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.$153,954
K99 · FY2024 · CA · contact PI
Defining kinase interaction pathways to enhance anti-cancer efficacy and minimize associated morbidities of kinase inhibitor drugs.$122,485
K99 · FY2023 · CA · contact PI